Investigational Site Number 826009

Oxford OX3 7LJ

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Hematopoietic Neoplasm

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma — Completed
• Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) — Completed